Matches in Wikidata for { <http://www.wikidata.org/entity/Q57285688> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q57285688 description "artículu científicu espublizáu n'avientu de 2018" @default.
- Q57285688 description "im Dezember 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57285688 description "scientific article published on 01 December 2018" @default.
- Q57285688 description "wetenschappelijk artikel" @default.
- Q57285688 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q57285688 name "Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting" @default.
- Q57285688 name "Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting" @default.
- Q57285688 type Item @default.
- Q57285688 label "Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting" @default.
- Q57285688 label "Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting" @default.
- Q57285688 prefLabel "Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting" @default.
- Q57285688 prefLabel "Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting" @default.
- Q57285688 P1433 Q57285688-4C6504BF-0174-449D-862F-3D38C6F2AE10 @default.
- Q57285688 P1476 Q57285688-6C5119B6-8B52-4152-9647-228D774A3EBD @default.
- Q57285688 P2093 Q57285688-2BCEF5B3-3056-4AEA-96D9-1CA32850834F @default.
- Q57285688 P2093 Q57285688-5667E67B-82A7-4D29-AF49-0B4352583857 @default.
- Q57285688 P2093 Q57285688-9010431C-6CB6-4C57-9783-F74D4A2D771A @default.
- Q57285688 P2093 Q57285688-DEB52527-9DCA-4CAE-93B7-97E6BBE87F04 @default.
- Q57285688 P304 Q57285688-F93CED70-8CA4-455E-B0B2-86596811F479 @default.
- Q57285688 P31 Q57285688-19572DE5-A780-46EB-B2DB-DAAE435AD03B @default.
- Q57285688 P356 Q57285688-BC29AF4F-AADD-4BBD-95BC-CD74D8CBCE97 @default.
- Q57285688 P407 Q57285688-51EE28C8-AFC6-4B4D-8DD5-4CAD37C1EA0F @default.
- Q57285688 P433 Q57285688-7F704DEE-896B-4AC4-BC93-00DC3AF82BF7 @default.
- Q57285688 P478 Q57285688-DC087558-2F28-41F0-9FE4-DA4AD7633A3E @default.
- Q57285688 P577 Q57285688-4EAD00A3-26E9-41EA-9B7C-67696D219966 @default.
- Q57285688 P698 Q57285688-C03E1E95-AE12-494E-98FB-7E50E81EDB33 @default.
- Q57285688 P356 MNM.0000000000000926 @default.
- Q57285688 P698 30308585 @default.
- Q57285688 P1433 Q15757925 @default.
- Q57285688 P1476 "Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting" @default.
- Q57285688 P2093 "Anant Ramaswamy" @default.
- Q57285688 P2093 "Ashwini Kalshetty" @default.
- Q57285688 P2093 "Sandip Basu" @default.
- Q57285688 P2093 "Vikas Ostwal" @default.
- Q57285688 P304 "1143-1149" @default.
- Q57285688 P31 Q13442814 @default.
- Q57285688 P356 "10.1097/MNM.0000000000000926" @default.
- Q57285688 P407 Q1860 @default.
- Q57285688 P433 "12" @default.
- Q57285688 P478 "39" @default.
- Q57285688 P577 "2018-12-01T00:00:00Z" @default.
- Q57285688 P698 "30308585" @default.